A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer
Status:
Recruiting
Trial end date:
2024-01-11
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-arm, phase Ib study to evaluate the safety and
efficacy of Mitoxantrone Hydrochloride Liposome in subjects with Platinum-Resistant or
Platinum-Refractory Relapsed Ovarian Cancer.